Evidence map›Paper›PMID 30202398›Full record

ArticleHereditas2018

Overexpression of the

Fabienne E Bayer, Mirjam Zimmermann, Anette Preiss, Anja C Nagel

Open access · goldAbstract read
In one paragraph

Article in Hereditas, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Fabienne E Bayer *Universität Hohenheim, Institut für Genetik, Garbenstr. 30, 70599 Stuttgart, Germany.
Mirjam Zimmermann *Universität Hohenheim, Institut für Genetik, Garbenstr. 30, 70599 Stuttgart, Germany.
Anette PreissUniversität Hohenheim, Institut für Genetik, Garbenstr. 30, 70599 Stuttgart, Germany.
Anja C NagelUniversität Hohenheim, Institut für Genetik, Garbenstr. 30, 70599 Stuttgart, Germany.
University of Hohenheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDNA damage generally results in the activation of ATM/ATR kinases and the downstream checkpoint kinases Chk1/Chk2. In

resultsOverexpression of

conclusionWe conclude that overexpression of the

Indexed as

Cell Cycle CheckpointsDNA DamageAnimalsAnimals, Genetically ModifiedCell Cycle ProteinsCell DivisionDrosophila melanogasterDrosophila ProteinsG2 PhaseProtein Serine-Threonine KinasesCell Cycle ProteinsDrosophila ProteinsMei-41 protein, DrosophilaProtein Serine-Threonine KinasesATRDNA damage checkpointMei-41Overexpressionp53 activation

Identifiers

PMID30202398
PMCPMC6125995
OpenAlexW2890538656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.